Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on SANOFI mainly cover M&A activity. The stock trades at €76,03 on Euronext Paris, down 0,43% at the last update. This page lists the articles published on SANOFI stock to track the share price, company announcements and any item likely to influence market perception.
On July 21, Sanofi announced changes to its executive committee, effective September 1, 2026. This reorganization focuses power around business activi…
Following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi, Paulo Fontoura announced his resignatio…
The French pharmaceutical company marks one of the strongest gains in the CAC 40 by mid-morning. This movement follows the U.S. regulator's approval o…
The FDA has approved the subcutaneous formulation of Sarclisa, administered via an on-body injector, for the treatment of multiple myeloma. The drug b…
The pharmaceutical company marks one of the sharpest rebounds in the CAC 40 mid-morning, after a decline phase that had driven the stock below its mov…
Sanofi announced on Tuesday positive phase 3 results for Nexviazyme in treating the early-infantile form of Pompe disease in infants. The company plan…
On Thursday, the Sanofi Foundation announced a strategic reorientation towards supporting children and youth living with serious illnesses, combining …
Sanofi announced on Tuesday that Wayrilz (rilzabrutinib) has been approved by the Japanese Ministry of Health for the treatment of persistent or chron…
Sanofi announced on Tuesday the approval by the European Commission of Cenrifki (tolebrutinib) to treat secondary progressive multiple sclerosis (SPMS…
The pharmaceutical company significantly declines mid-morning and is among the worst performers on the CAC 40. The stock breaks through a closely watc…
